2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases-Reference-Cited by-同舟云学术

2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases

Published:2020-06-07 Issue:2 Volume:52 Page:276-283
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Taxonera Carlos¹^ORCID,Sagastagoitia Iñigo²^ORCID,Alba Cristina¹^ORCID,Mañas Norberto¹^ORCID,Olivares David¹^ORCID,Rey Enrique¹^ORCID

Affiliation:

1. Inflammatory Bowel Disease Unit; Department of Gastroenterology; Hospital Clínico San Carlos and Instituto de Investigación del Hospital Clínico San Carlos [IdISSC]; Madrid Spain

2. Department of Internal Medicine; Hospital Clínico San Carlos and Instituto de Investigación del Hospital Clínico San Carlos [IdISSC]; Madrid Spain

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15804/fullpdf

Reference34 articles.

1. World Health Organization Coronavirus disease (COVID-19) outbreak https://www.who.int

2. Clinical characteristics of coronavirus disease 2019 in China;Guan;N Engl J Med,2020

3. Clinical characteristics of 138 hospitalized patients With 2019 novel coronavirus-infected pneumonia in Wuhan, China;Wang;JAMA,2020

4. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet,2020

5. Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurines;Wisniewski;United Eur Gastroenterol J,2019

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Positive Psychological Interventions on Psychological Outcomes, Quality of Life, and Inflammation Biomarkers in Inflammatory Bowel Disease Patients: A Meta-Analysis of Randomized Controlled Trials;Gastroenterology Nursing;2024-09-05

2. Update des Addendums zu den S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Betreuung von Patienten mit chronisch-entzündlichen Darmerkrankungen in Bezug auf COVID-19 (Version 2.0);Zeitschrift für Gastroenterologie;2024-04

3. Inpatient outcomes of inflammatory bowel disease in hospitalized patients with COVID-19: analysis of a nationally representative sample;Baylor University Medical Center Proceedings;2024-01-26

4. Gastrointestinal Manifestations of COVID-19;Textbook of SARS-CoV-2 and COVID-19;2024

5. COVID-19 in patients with inflammatory bowel diseases: Characteristics and guidelines;Management, Body Systems, and Case Studies in COVID-19;2024